Cargando…
The Use of Specific Serological Biomarkers to Detect CaniLeish Vaccination in Dogs
Canine leishmaniosis (CanL) prevention in the Mediterranean basin is considered essential to stop human zoonotic visceral leishmaniasis. In this context, vaccination of dogs is expected to have a significant impact in disease control. CaniLeish® (Virbac Animal Health) is one of a few CanL vaccines t...
Autores principales: | Lima, Carla, Santarém, Nuno, Nieto, Javier, Moreno, Javier, Carrillo, Eugenia, Bartholomeu, Daniella Castanheira, Bueno, Lilian Lacerda, Fujiwara, Ricardo, Amorim, Célia, Cordeiro-da-Silva, Anabela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821643/ https://www.ncbi.nlm.nih.gov/pubmed/31709270 http://dx.doi.org/10.3389/fvets.2019.00373 |
Ejemplares similares
-
Hematological, Biochemical, and Serological Findings in Healthy Canine Blood Donors after the Administration of CaniLeish® Vaccine
por: Starita, Chiara, et al.
Publicado: (2016) -
Use of a LiESP/QA-21 Vaccine (CaniLeish) Stimulates an Appropriate Th1-Dominated Cell-Mediated Immune Response in Dogs
por: Moreno, Javier, et al.
Publicado: (2012) -
The protective immune response produced in dogs after primary vaccination with the LiESP/QA-21 vaccine (CaniLeish(®)) remains effective against an experimental challenge one year later
por: Martin, Virginie, et al.
Publicado: (2014) -
Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis
por: Santarém, Nuno, et al.
Publicado: (2020) -
Author Correction: Challenges in the serological evaluation of dogs clinically suspect for canine leishmaniasis
por: Santarém, Nuno, et al.
Publicado: (2020)